Biovex
- Company typePrivate
- Founded-
- HeadquartersRas Al Khaimah, United Arab Emirates
- Headcount11–50
- GTM typeB2B
- OfferingServices
Biovex firmographics
Firmographics- Name
- Biovex
- Legal name
- Biovex International Trading FZ LLC
- Website
- https://biovexhealthcare.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Biovex industry classification
Industry- Product category
- Pharmaceutical Distribution
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Veterinary Vaccine & Biologics Distributors (HLAMAIAC)
Keywords
Where Biovex is headquartered
LocationHeadquarters
- HQ city
- Ras Al Khaimah
- HQ country
- United Arab Emirates
- HQ region
- Middle East
Offices1 record
Markets served
Biovex business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D
Revenue model
- Vaccine Distribution: Sourcing and exporting human vaccines (bacterial and viral) and veterinary vaccines to international markets, primarily through government and institutional tender channels.
- Blood Derivatives: Distribution of blood derivative products including human albumin, immunoglobulins, and factor VIII for medical treatments.
- Specialty Products: Supply of antivenoms (snake and scorpion), botulinum toxin, rabies antiserum, and recombinant growth factors.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
Biovex product offering
Product offeringCore offering
Biovex International Trading FZ LLC is an international trading company that sources and distributes human vaccines (bacterial and viral), veterinary vaccines, blood derivatives, and specialty biological products. The company procures WHO pre-qualified products from international manufacturers and exports them primarily through government and institutional tenders, with specialized cold chain logistics for temperature-sensitive biologics.
Product overview
Biovex International Trading FZ LLC is a pharmaceutical trading company offering a comprehensive portfolio of human and veterinary vaccines, blood derivatives, and specialty biological products. The core offerings include Bacterial Human Vaccines (BCG, Oral Cholera, Meningococcal, Typhoid), Viral Human Vaccines (Oral Polio, Rabies, Yellow Fever, Hepatitis B, Rotavirus, H1N1), and Veterinary Vaccines categorized by animal type (Poultry, Cattle, Sheep & Goat, Dog). Supporting products include Blood Derivatives (Human Normal Albumin, Human Normal Immunoglobulin, Dried Factor VIII) and Specialty Products (Snake Venom Antiserum, Botulinum Toxin, Rabies Antiserum, Recombinant Human EGF Gel, Anti-Scorpion Venom, Saccharomyces Boulardii). The company operates as a trading/distribution entity sourcing products from international manufacturers and exporting to 13+ African countries and 5+ Asian countries.
Differentiator
Problem solved
Functional benefit
Companies that use Biovex
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles4 records
Biovex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Biovex partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
Biovex competitors and assessment
Company assessmentBroad incumbents
- Sanofi Pasteur: Major global vaccine manufacturer and Sanofi's vaccines division. Competes with Biovex in emerging markets through direct distribution and supply to government immunization programs across Africa and Asia.
- GSK: Major global vaccine manufacturer with broad portfolio across pediatric, travel, and adult vaccines. Biovex competes indirectly by offering WHO pre-qualified alternatives in emerging markets where GSK also distributes directly to governments.
Regional players
- PT Bio Farma: Indonesian state-owned vaccine manufacturer, primarily serves domestic and ASEAN markets. Comparable in product portfolio (human and veterinary vaccines) and government procurement focus, though primarily focused on Indonesia.
Direct peers
- Biological E. Limited: Indian vaccine manufacturer with portfolio including DPT, measles, hepatitis, and other vaccines for emerging markets. Comparable in scale, target geographies, and government tender focus.
- Bharat Biotech: Indian vaccine manufacturer with focus on emerging markets, including polio, rabies, rotavirus, and typhoid vaccines. Comparable in product categories, WHO pre-qualified product mix, and export-focused B2B model serving government immunization programs.
- Panacea Biotec: Indian vaccine manufacturer with portfolio including polio, DPT, and other vaccines. Comparable in emerging market focus and B2B distribution model through government and institutional channels.
- Sinovac Biotech: Chinese vaccine manufacturer with focus on emerging markets, including hepatitis, flu, and COVID vaccines. Comparable in export focus and B2B model serving government immunization programs in developing countries.
- Serum Institute of India: Largest vaccine manufacturer globally, exporting to 170+ countries including African and Asian government markets. Directly comparable in product portfolio (human vaccines such as polio, measles, BCG) and B2B export focus through institutional channels.
- Indian Immunologicals Limited: Indian vaccine manufacturer for both human and veterinary use, with strong emerging market presence. Comparable in product mix including veterinary vaccines and footprint in African and Asian government markets.
Emerging players
- Haffkine Bio-Pharmaceutical Corporation: Indian state-owned vaccine and pharmaceutical manufacturer. Comparable in product portfolio including bacterial and viral vaccines and emerging market focus, though primarily serves domestic Indian markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Biovex compliance and trust
Trust signalCompliance3 records
Biovex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biovex leadership team
Management profileNumber of profiles
Biovex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biovex M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biovex
What does Biovex do?
Biovex International Trading FZ LLC is an international trading company that sources and distributes human vaccines (bacterial and viral), veterinary vaccines, blood derivatives, and specialty biological products. The company procures WHO pre-qualified products from international manufacturers and exports them primarily through government and institutional tenders, with specialized cold chain logistics for temperature-sensitive biologics.
Is Biovex a public or private company?
Biovex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Biovex founded?
Biovex was founded in -1. It employs 11 to 50 people.
Where is Biovex based?
Biovex is headquartered in Ras Al Khaimah, United Arab Emirates, in the Middle East region.
How does Biovex make money?
Three revenue lines are on record. Vaccine Distribution is the primary driver. The others are blood Derivatives and specialty Products.
Who are Biovex's main competitors?
Broad incumbents on record are Sanofi Pasteur and GSK. PT Bio Farma is listed as a regional player. Direct peers are Biological E. Limited, Bharat Biotech, Panacea Biotec, Sinovac Biotech, Serum Institute of India and Indian Immunologicals Limited. Haffkine Bio-Pharmaceutical Corporation is listed as an emerging player.
Does Biovex have an API?
No public API is recorded for Biovex.
What industry is Biovex in?
Biovex's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAMAIAC, Veterinary Vaccine & Biologics Distributors. Its SIC code is 2836.